Outcomes and prognostic factors in nodular melanomas

Surgery (United States)

Volumn 152, Issue 4, 2012, Pages 652-660

  Egger, Michael E ^a   Dunki Jacobs, Erik M ^a   Callender, Glenda G ^a   Quillo, Amy R ^a   Scoggins, Charles R ^a   Martin II, Robert C G ^a   Stromberg, Arnold J ^a   McMasters, Kelly M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDEPENDENT VARIABLE; KAPLAN MEIER METHOD; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POST HOC ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SKIN ULCER; UNIVARIATE ANALYSIS;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SKIN ULCER; TREATMENT OUTCOME;

EID: 84867075692     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.07.006     Document Type: Article

References (25)

1. V.J. McGovern, M.C. Mihm Jr., and C. Bailly The classification of malignant melanoma and its histologic reporting Cancer 32 1973 1446 1457
2. A.J. Chamberlain, L. Fritschi, G.G. Giles, J.P. Dowling, and J.W. Kelly Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia Arch Dermatol 138 2002 609 614
3. M.A. Warycha, P.J. Christos, and M. Mazumdar Changes in the presentation of nodular and superficial spreading melanomas over 35 years Cancer 113 2008 3341 3348
4. M.F. Demierre, C. Chung, D.R. Miller, and A.C. Geller Early detection of thick melanomas in the United States: beware of the nodular subtype Arch Dermatol 141 2005 745 750
5. W.R. Shaikh, M. Xiong, and M.A. Weinstock The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007 Arch Dermatol 148 2012 30 36
6. H.S. Greenwald, E.B. Friedman, and I. Osman Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model Melanoma Res 22 2012 1 8
7. A. Konstantina, A.C. Lazaris, E. Ioannidis, A. Liossi, and K. Aroni Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi Melanoma Res 21 2011 389 394
8. L.A. Akslen, S. Angelini, and O. Straume BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival J Invest Dermatol 125 2005 312 317
9. J.H. Lee, J.W. Choi, and Y.S. Kim Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis Br J Dermatol 164 2011 776 784
10. K.M. McMasters, R.D. Noyes, and D.S. Reintgen Lessons learned from the Sunbelt Melanoma Trial J Surg Oncol 86 2004 212 223
11. M.G. Statius Muller, P.A. van Leeuwen, and E.S. de Lange-De Klerk The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma Cancer 91 2001 2401 2408
12. K.M. McMasters, S.L. Wong, and M.J. Edwards Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma Surgery 130 2001 151 156
13. A. Cadili, and K. Dabbs Predictors of sentinel lymph node metastasis in melanoma Can J Surg 53 2010 32 36
14. C. Kunte, T. Geimer, and J. Baumert Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma Melanoma Res 20 2010 330 337
15. R.E. Brown, M.I. Ross, and M.J. Edwards The prognostic significance of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 17 2010 3330 3335
16. A.A. Ghaferi, S.L. Wong, and T.M. Johnson Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma Ann Surg Oncol 16 2009 2978 2984
17. C. Ariyan, M.S. Brady, M. Gonen, K. Busam, and D. Coit Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma Ann Surg Oncol 16 2009 186 190
18. R. Murali, C. Desilva, J.F. Thompson, and R.A. Scolyer Factors predicting recurrence and survival in sentinel lymph node-positive melanoma patients Ann Surg 253 2011 1155 1164
19. J.A. Brauer, C.C. Wriston, and A.B. Troxel Characteristics associated with early and late melanoma metastases Cancer 116 2010 415 423
20. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
21. P.F. Austin, C.W. Cruse, G. Lyman, K. Schroer, F. Glass, and D.S. Reintgen Age as a prognostic factor in the malignant melanoma population Ann Surg Oncol 1 1994 487 494
22. C. Chao, R.C. Martin 2nd, and M.I. Ross Correlation between prognostic factors and increasing age in melanoma Ann Surg Oncol 11 2004 259 264
23. C.R. Scoggins, M.I. Ross, and D.S. Reintgen Gender-related differences in outcome for melanoma patients Ann Surg 243 2006 693 698
24. C. Lindholm, R. Andersson, and M. Dufmats Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors Cancer 101 2004 2067 2078
25. McMasters KM. Final results of the Sunbelt Melanoma Trial. In: ASCO Annual Meeting 2008.